Thioredoxin binding protein-2 mediates metabolic adaptation in response to lipopolysaccharide in vivo

Critical Care Medicine

Volumn 38, Issue 12, 2010, Pages 2345-2351

  Oka, Shin Ichi ^a   Liu, Wenrui ^a   Yoshihara, Eiji ^a   Ahsan, Md Kaimul ^b   Ramos, Dorys Adriana Lopez ^a   Son, Aoi ^a   Okuyama, Hiroaki ^b   Zhang, Li ^c   Masutani, Hiroshi ^a   Nakamura, Hajime ^b   Yodoi, Junji ^a,b  

^a KYOTO UNIVERSITY   (Japan)

^b KYOTO UNIVERSITY HOSPITAL   (Japan)

^c WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

endotoxemia; fatty acid oxidation disorder; hyperinsulinemia; hyperlipidemia; hypoglycemia; thioredoxin binding protein 2 (TBP 2) Txnip Vdup1

Indexed keywords

CHOLESTEROL; CYTOKINE; FATTY ACID; GLUCOSE; INSULIN; LIPID; LIPOPOLYSACCHARIDE; PROTEIN KINASE B; THIOREDOXIN INTERACTING PROTEIN; TRIACYLGLYCEROL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROL GROUP; CONTROLLED STUDY; CYTOKINE STORM; DEATH; DISEASE MARKER; DISEASE PREDISPOSITION; ENDOTOXEMIA; ENZYME LINKED IMMUNOSORBENT ASSAY; EXPERIMENTAL MODEL; FATTY ACID OXIDATION; GLUCONEOGENESIS; HYPERINSULINEMIA; HYPOGLYCEMIA; IN VIVO STUDY; KIDNEY; KIDNEY INJURY; KNOCKOUT MOUSE; LIPID BLOOD LEVEL; LIPID STORAGE; LIVER; METABOLIC REGULATION; MORTALITY; MOUSE; NONHUMAN; ORGAN INJURY; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN PHOSPHORYLATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

EID: 78650305928     PISSN: 00903493     EISSN: 15300293     Source Type: Journal    
DOI: 10.1097/CCM.0b013e3181f85b2a     Document Type: Article

References (29)

1. Angus DC, Linde-Zwirble WT, Lidicker J, et al: Epidemiology of severe sepsis in the United States: Analysis of incidence, outcome, and associated costs of care. Crit Care Med 2001; 29:1303-1310
2. Parrillo JE: Septic shock-Vasopressin, norepinephrine, and urgency. N Engl J Med 2008; 358:954-956
3. Herrema H, Derks TG, van Dijk TH, et al: Disturbed hepatic carbohydrate management during high metabolic demand in medium-chain acyl-CoA dehydrogenase (MCAD)-deficient mice. Hepatology 2008; 47: 1894-1904
4. Almeida A, Cidad P, Bolanos JP: Nitric oxide accounts for an increased glycolytic rate in activated astrocytes through a glycogenoly-sis-independent mechanism. Brain Res 2002; 945:131-134
5. Barke RA, Brady PS, Brady LJ: The Ca2+ second messenger system and interleukin-1-alpha modulation of hepatic gene transcription and mitochondrial fat oxidation. Surgery 1991; 110:285-294
6. Nanni G, Siegel JH, Coleman B, et al: Increased lipid fuel dependence in the critically ill septic patient. J Trauma 1984; 24:14-30
7. Yamamoto T: Rat liver peroxisomal and mitochondrial fatty acid oxidation in sepsis. Surg Today 1993; 23:137-143
8. Crouser ED, Julian MW, Huff JE, et al: Abnormal permeability of inner and outer mitochondrial membranes contributes independently to mitochondrial dysfunction in the liver during acute endotoxemia. Crit Care Med 2004; 32:478-488
9. Kantrow SP, Taylor DE, Carraway MS, et al: Oxidative metabolism in rat hepatocytes and mitochondria during sepsis. Arch Biochem Biophys 1997; 345:278-288
10. Mela-Riker L, Bartos D, Vlessis AA, et al: Chronic hyperdynamic sepsis in the rat. II. Characterization of liver and muscle energy metabolism. Circ Shock 1992; 36:83-92
11. Harris HW, Gosnell JE, Kumwenda ZL: The lipemia of sepsis: Triglyceride-rich lipopro-teins as agents of innate immunity. J Endo-toxin Res 2000; 6:421-430
12. Koskinas J, Gomatos IP, Tiniakos DG, et al: Liver histology in ICU patients dying from sepsis: A clinico-pathological study. World J Gastroenterol 2008; 14:1389-1393
13. Krinsley JS: The severity of sepsis: Yet another factor influencing glycemic control. Crit Care 2008; 12:194
14. Shcherbakova LN, Iakovleva, II, Molchanova LV: [Basic characteristics of lipid metabolism in patients with sepsis during kidney replacement therapy]. Anesteziol Reanimatol 2003: 27-29
15. Sim KG, Hammond J, Wilcken B: Strategies for the diagnosis of mitochondrial fatty acid beta-oxidation disorders. Clin Chim Acta 2002; 323:37-58
16. Nishiyama A, Matsui M, Iwata S, et al: Identification of thioredoxin-binding protein-2/ vitamin D(3) up-regulated protein 1 as a negative regulator of thioredoxin function and expression. J Biol Chem 1999; 274: 21645-21650
17. Patwari P, Higgins LJ, Chutkow WA, et al: The interaction of thioredoxin with Txnip. Evidence for formation of a mixed disulfide by disulfide exchange. J Biol Chem 2006; 281:21884-21891
18. Junn E, Han SH, Im JY, et al: Vitamin D3 up-regulated protein 1 mediates oxidative stress via suppressing the thioredoxin function. J Immunol 2000; 164:6287-6295
19. Ahsan MK, Masutani H, Yamaguchi Y, et al: Loss of interleukin-2- dependency in HTLV-I-infected T cells on gene silencing of thiore-doxin-binding protein-2. Oncogene 2006; 25: 2181-2191
20. Oka S, Liu W, Masutani H, et al: Impaired fatty acid utilization in thioredoxin binding protein-2 (TBP-2)-deficient mice: A unique animal model of Reye syndrome. FASEB J 2006; 20:121-123
21. Okuyama H, Yoshida T, Son A, et al: Thiore-doxin binding protein 2 modulates natural killer T cell-dependent innate immunity in the liver: Possible link to lipid metabolism. Antioxid Redox Signal 2009; 11:2585-2593
22. Bodnar JS, Chatterjee A, Castellani LW, et al: Positional cloning of the combined hyperlip-idemia gene Hyplip1. Nat Genet 2002; 30: 110-116
23. Oka S, Yoshihara E, Bizen-Abe A, et al: Thi-oredoxin binding protein-2/thioredoxin-interacting protein is a critical regulator of insulin secretion and peroxisome prolifera-tor-activated receptor function. Endocrinology 2009; 150:1225-1234
24. Puigserver P, Rhee J, Donovan J, et al: Insulin-regulated hepatic gluconeogenesis through FOXO1-PGC-1alpha interaction. Nature 2003; 423:550-555
25. Saudubray JM, Martin D, de Lonlay P, et al: Recognition and management of fatty acid oxidation defects: A series of 107 patients. J Inherit Metab Dis 1999; 22:488-502
26. Vriesendorp TM, DeVries JH, Hoekstra JB: Hypoglycemia and strict glycemic control in critically ill patients. Curr Opin Crit Care 2008; 14:397-402
27. Fredriksson K, Tjader I, Keller P, et al: Dys-regulation of mitochondrial dynamics and the muscle transcriptome in ICU patients suffering from sepsis induced multiple organ failure. PLoS ONE 2008; 3:e3686
28. Hui TY, Sheth SS, Diffley JM, et al: Mice lacking thioredoxin-interacting protein provide evidence linking cellular redox state to appropriate response to nutritional signals. J Biol Chem 2004; 279:24387-24393
29. Alamdari N, Constantin-Teodosiu D, Murton AJ, et al: Temporal changes in the involvement of pyruvate dehydrogenase complex in muscle lactate accumulation during lipo-polysaccharide infusion in rats. J Physiol 2008; 586:1767-1775